Page URL: https://www.bionews.org.uk/page_159709

Huntington's gene found to affect development of two-week-old embryos

11 October 2021
Appeared in BioNews 1116

Researchers have discovered the earliest known effect of the Huntingtin (Htt) gene variant which causes Huntington's disease (HD). 

While people are mostly diagnosed with HD in midlife, this is often after the gene has already affected neurons in the patient's brain. Now, using synthetic embryo-like structures known as 'gastruloids' (see BioNews 1072) made from human embryonic stem cell, researchers from the Laboratory of Synthetic Embryology at Rockefeller University, New York have shown the gene variant affects the human embryo during a phase known as gastrulation, which occurs around two weeks after fertilisation

'When the patient goes to the doctor, that’s when the last dominoes have fallen. But the first domino is pushed in the developmental phase,' said Professor Ali Brivanlou, head of the Laboratory of Synthetic Embryology at Rockefeller University. 'Knowing this trajectory, we may be able to block the progression of the disease.'

HD is an inherited degenerative condition caused by a faulty gene that affects the nerve cells in the brain over time. Patients die around 20 years after initial diagnosis, which mainly occurs between the ages of 30-50, though there is thought to be a prodromal phase of 7-10 years for some patients before the main onset of symptoms. Symptoms include problems with motor control, swallowing and speaking, difficulty concentrating and memory lapses, depression and personality changes. Parents who have the condition have a 50 percent chance of passing it on to their children. 

The existence of too many CAG repeats on the Htt gene is behind the problems experienced by people with HD, and evidence suggests the longer the length of these repeats, the more severe the symptoms and the earlier onset of the disease is. 

The team had previously discovered that changes occur in the brains of embryos with the faulty Htt gene just as they start to develop. In their latest research published in the journal Development they created synthetic embryo-like structures with normal and HD-like CAG repeat lengths on the Htt gene using CRISPR/Cas9 editing. 

They showed changes in the cell signalling occurred as gastrulation started, which led to the differentiated germ layers having different sizes when compared to the structures created without the faulty gene variants. The effect was more pronounced the higher the number of CAG repeats on the gene variant used. 'It's a phenotypic signature – you can see it with your eyes,' said Professor Brivanlou.

Next researchers want to find out how the embryo corrects for some of the changes that occur at gastrulation, as patients are often symptom free for decades before diagnosis. 'Understanding those mechanisms may be the key to developing new treatments that delay the symptoms, or even cure the disease,' Professor Brivanlou said.

SOURCES & REFERENCES
Huntingtin CAG expansion impairs germ layer patterning in synthetic human 2D gastruloids through polarity defects
Development |  5 October 2021
Huntington’s Disease effects detected in first two weeks of embryonic development
Genetic Engineering & Biotechnology News |  6 October 2021
Study detects origins of Huntington's disease in two-week-old human embryos
The Rockefeller University |  5 October 2021
Tracing Huntington's Disease back to gastrulation
Development |  7 October 2021
Two-week-old human embryos reveal origin of Huntington’s disease
Drug Target Review |  6 October 2021
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
11 October 2021 - by Ana Pereira Daoud 
Our scientific understanding of early human embryogenesis is the product of costly trade-offs...
6 September 2021 - by Jessica Peixinho 
A mechanism for boosting the activity of a DNA repair protein involved in Huntington's disease has been discovered, creating a potential treatment avenue...
2 March 2020 - by Jen Willows 
A UK woman who sued her father's doctors because they did not inform her of her risk of Huntington's disease has lost her case...
12 June 2017 - by Dr Lea Goetz 
Scientists have identified the first promising biomarker for Huntington's disease (HD) that could be harnessed in a simple blood test to predict disease onset and progression...
3 August 2015 - by Dr Victoria Burchell 
A genome-wide study of over 4000 people with Huntington's disease has identified the location several new gene variants that influence the onset of disease symptoms...
11 November 2013 - by Dr Anna Cauldwell 
A molecular technique that enables any part of the human genome to be altered with extreme precision has been hailed by scientists as a breakthrough in genetics...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.